Ozempic social media dataset

Sample data

[ { "platform": "[redacted]", "type": "content", "content_type": "text", "id": "t3_1s75cg7", "url": "[redacted]", "title": "Anhedonia question", "text": "I'm wondering if people experience less anhedonia on semaglutide than tirzepatide due to how it affects dopamine differently...", "text_snippet": null, "timestamp": "2026-03-29T20:02:00Z", "lang": "en", "hashtags": null, "author": {"id": "t2_151yyu", "username": "Wellslapmesilly"}, "engagement": {"like_count": 8, "comment_count": 7}, "media": null, "metadata": {"flair": "Practical GLP-1 Questions"} }, { "platform": "[redacted]", "type": "content", "content_type": "text", "id": "3mhyridlips2r", "url": "[redacted]", "title": null, "text": "This week's Lancet cover and editorial about getting GLP-1 drugs available for the people who need them most...", "text_snippet": null, "timestamp": "2026-03-26T23:37:03Z", "lang": "en", "hashtags": [], "author": {"id": "did:plc:6vwezbhj7wwowu4sbur5npjk", "username": "erictopol", "display_name": "Eric Topol", "verified": true}, "engagement": {"like_count": 75, "comment_count": 1, "share_count": 17, "bookmark_count": 4}, "media": [{"type": "link", "url": "[redacted]"}], "metadata": null }, { "platform": "[redacted]", "type": "content", "content_type": "video", "id": "Woj-qPpJ63o", "url": "[redacted]", "title": "Morgan Stanley on GLP-1 adoption impact", "text": "Morgan Stanley's Brian Harbour joins Closing Bell Overtime to talk higher GLP-1 adoption impacting quick service restaurants.", "text_snippet": null, "timestamp": "2026-03-26T01:25:24Z", "lang": "en", "hashtags": [], "author": {"id": "UCrp_UI8XtuYfpiqluWLD7Lw", "username": "CNBCtelevision", "display_name": "CNBC Television"}, "engagement": {"view_count": 1569, "like_count": 16, "comment_count": 2}, "media": [{"type": "video", "url": "[redacted]", "duration": "00:04:09"}], "metadata": null } ]